KIMS Q1 FY27 Net Profit Rises 13% YoY

Reporting Period (Quarter/Year): Quarter ended 30 June 2026 (Q1 FY27)

Nature of Filing / Announcement: Outcome of Board Meeting pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015

Audit Opinion: Unmodified review opinion (clean)

Auditor's Comment: Nothing has come to our attention that causes us to believe that the Statement contains any material misstatement

Auditor: S.R. Batliboi & Associates LLP

Revenue from Operations: ₹4,836 million (Q1 FY27) vs ₹3,734 million (Q1 FY26) - 29.5% YoY increase

Total Income: ₹5,143 million (Q1 FY27)

Net Profit: ₹665 million (Q1 FY27) vs ₹588 million (Q1 FY26) - 13% YoY increase

EPS: Basic ₹1.66, Diluted ₹1.66 (not annualized)

Other Equity: ₹23,487 million

Revenue from Operations: ₹11,795 million (Q1 FY27) vs ₹8,716 million (Q1 FY26) - 35.3% YoY increase

Total Income: ₹11,959 million (Q1 FY27)

Net Profit: ₹374 million (Q1 FY27) vs ₹850 million (Q1 FY26) - 56% YoY decrease

Net Profit Attributable to Owners: ₹415 million (Q1 FY27)

EPS: Basic ₹1.04, Diluted ₹1.04 (not annualized)

Other Equity: ₹21,674 million

The Company operates in one single reportable business segment "Medical and Healthcare services"

Completed Qualified Institutions Placement (QIP) of 19,867,549 equity shares of face value ₹2 each at issue price of ₹755 per share (including securities premium of ₹753 per share), aggregating ₹15,000 million
Approved raising funds through issuance of up to 7,702,182 convertible warrants at issue price of ₹779 per warrant, aggregating up to ₹6,000 million on preferential basis to promoters and promoter group entities
Warrants convertible into equity shares within 18 months from date of allotment
Approved loan limit of ₹650 Crores for subsidiaries/associates/joint ventures/group entities
Approved specific loan of up to ₹25 crore to KIMS Hospital Enterprises Private Limited (material subsidiary)

Funds from QIP (net of issue expenses of ₹237 million) utilized towards objects stated in Placement Document, balance temporarily invested in mutual funds
Consolidated results include subsidiaries: Iconkrishi Institute of Medical Sciences Private Limited, Saveera Institute of Medical Sciences Private Limited, KIMS Hospital Kurnool Private Limited, KIMS Hospitals Private Limited, KIMS Swastha Private Limited, KIMS Hospital Bengaluru Private Limited, Sarvejana Healthcare Private Limited, SPANV Medisearch Lifesciences Private Limited, KIMS Manavata Hospitals Private Limited, Meda Institute of Podiatry Private Limited, Chalasani Hospitals Private Limited, and associate: Kondapur Healthcare Limited
Three subsidiaries contributed total revenue of ₹403 million, total net loss after tax of ₹46 million
Associate contributed Group's share of net profit of ₹10 million